PGEN
PRECIGEN, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.95
−5.81%Forward multiples
Based on analyst estimates
- P/E forward
- 7.26x
- P/E 2026E
- 30.27x
- P/E 2027E
- 7.84x
- P/E 2028E
- 6.98x
- P/S forward
- 5.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 40.63x
- Price / sales
- 20.65x
- Price / cash flow
- -15.51x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 21.36x
- EV / EBITDA
- -12.73x
- EV / EBIT
- -46.35x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026